x

Posted 18 March, 2024

Healthcare Triangle, Inc. appointed Mr. Anand Kumar as new CEO

Nasdaq:HCTI appointed new Chief Executive Officer Mr. Anand Kumar in a 8-K filed on 18 March, 2024.


  On March 14, 2024, Healthcare Triangle, Inc., a Delaware corporation (the "Company"), appointed Mr. Anand Kumar, as interim chief executive officer of the Company (the "Interim CEO"), effective March 15, 2024 (the "Effective Date").  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Healthcare Triangle, Inc.
Technology • Software
Healthcare Triangle, Inc. operates as a healthcare information technology company, which engages in advancing various solutions for the cloud services, data science, and professional and managed services sectors for the healthcare and life sciences industry. It operates through the following segments: Software Services, Managed Services and Support, and Platform Services. The Software Services segment focuses on the sale of software services that are generated from providing strategic advisory, implementation, and development services. The Managed Services and Support segment includes post implementation support and cloud hosting. The Platform services segment offers solutions under CloudEz, DataEz, and Readabl.AI. The company was founded on October 29, 2019 and is headquartered in Pleasanton, CA.
Market Cap
$8.96M
View Company Details
Healthcare Triangle, Inc. by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On March 14, 2024, Healthcare Triangle, Inc., a Delaware corporation (the "Company"), appointed Mr. Anand Kumar, as interim chief executive officer of the Company (the "Interim CEO"), effective March 15, 2024 (the "Effective Date"). Mr. Kumar will continue to serve as the Chief Revenue Officer of the Company, in addition to the responsibilities of an Interim CEO.


In connection with his appointment as Interim CEO, the Company has entered into an offer letter with Mr. Kumar, which will become effective as of the Effective Date (the "Offer Letter"), pursuant to which Mr. Kumar will receive an annual base salary of $240,000 in the aggregate, along with being entitled to all benefits available to other executives of the Company, including without limitation: health, dental, vision coverage, flexible spending account, and life insurance, voluntary benefits insurance, and the Company's 401K Plan, subject to the terms and conditions of such plans and programs.


Mr. Kumar, who has served as the Company's Chief Revenue Officer since 2022, has more than 14 years of leadership and commercial experience. Mr. Kumar began his career at Elind in 1998 as Software Engineer, and served as S.V.P. at Cross Identity, Inc. from 2010 to 2012 & Managing Director at Mycroft, Inc, from 2012-2013 prior to joining SecureKloud Technologies, Inc. as Vice President for Cloud in 2013. Mr. Kumar served as Sr. Vice President and Head of Cloud Solutions at Healthcare Triangle, Inc. from 2020, leading the development and launch of Cloud and Data Platform, and was subsequently promoted to Sr. Vice President and Chief Revenue Officer within the Company. He is recognized throughout the industry as a seasoned executive and leader with extensive experience in Cybersecurity, Cloud, Data and Artificial Intelligence.


Mr. Kumar received his Bachelor's in Computer Science in 1995, Masters in Computer Science from Moscow State University in 1997 and Masters in Business Administration from Illinois Tech in 2003, and is currently pursuing his Global C-Suite program at Wharton Business School .


There are no arrangements or understandings between Mr. Kumar and any other persons pursuant to which he was selected as Interim CEO. There are also no family relationships between Mr. Kumar and any director or executive officer of the Company and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.